Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2193-2198

  Sakano, Katsuhisa ^a   Takahashi, Mami ^a   Mutoh, Michihiro ^a   Niho, Naoko ^a   Komiya, Masami ^a   Sato, Hidetaka ^b   Tanaka, Takuji ^c   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JAPAN FOOD RESEARCH LABORATORIES   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; CARCINOGEN; CHOLESTEROL; GLUCOSE; INSULIN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANAPLASTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHOLESTEROL BLOOD LEVEL; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FIBROSIS; FREQUENCY ANALYSIS; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PANCREAS CANCER; PHOSPHOLIPID BLOOD LEVEL; PRECANCER; PRIORITY JOURNAL; RAT; THYROID CANCER; THYROID CARCINOMA; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CARCINOGENS; COLONIC NEOPLASMS; DIABETES MELLITUS, TYPE 2; INJECTIONS, SUBCUTANEOUS; MALE; NITROSAMINES; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; RISK FACTORS; SPECIES SPECIFICITY; THYROID NEOPLASMS;

EID: 35148894480     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm114     Document Type: Article

References (41)

1. Czyzyk,A. et al. (2000) Diabetes mellitus and cancer. Eur. J. Intern. Med., 11, 242-252.
2. La Vecchia,C. et al. (1994) A case-control study of diabetes mellitus and cancer risk. Br. J. Cancer., 70, 950-953.
3. Zivaljevic,V. et al. (2004) Case-control study of anaplastic thyroid cancer. Tumori, 90, 9-12.
4. Bruce,W.R. et al. (2000) Mechanisms linking diet and colorectal cancer: The possible role of insulin resistance. Nutr Cancer., 37, 19-26.
5. Le Marchand,L. et al. (1997) Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res., 57, 4787-4794.
6. Calle,E.E. et al. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med., 348, 1625-1638.
7. Michaud,D.S. et al. (2001) Physical aetivity, obesity, height, and the risk of pancreatic cancer. JAMA, 286, 921-929.
8. Kawano,K et al. (1992) Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes, 41, 1422-1428.
9. Kawano,K. et al. (1991) A new rat strain with non-insulin dependent diabetes mellitus, "OLETF". Rat News Lett., 25, 24-26.
10. Sato,T. et al. (1995) Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM. Diabetologia 38, 1033-1041.
11. Kondo,M. et al. (2000) Atypical hyperplasia, of choledocho-pancreatic duct epithelium in an Otsuka Long Evans Tokushima Fatty strain of rats. Pathol. Int., 50, 126-135.
12. Konishi,Y. et al. (1998) Mechanistic analysis of pancreatic ductal carcinogenesis in hamsters. Pancreas, 16, 300-306.
13. Pour,P. et al. (1977) A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis (2-oxopropyl)amine. J. Natl. Cancer Inst., 58, 1449-1453.
14. Ketkar,M.B. et al. (1984) The carcinogenic effect of bis(2-oxopropyl)-nitrosamine on Sprague-Dawley rats. Cancer Lett., 24, 73-79.
15. Lijinsky,W. et al. (1983) Carcinogenesis in Fischer rats by nitrosodipropyl-amine, nitrosodibutylamine and nitrosobis(2-oxopropyl)amine given by gavage. Cancer Lett., 19 207-213.
16. Pour,P. et al. (1978) Induction of thyroid follicular adenomas and carcinomas by N-nitrosobis(2-oxopropyl)amine. Cancer Lett., 5, 13-18.
17. Kawaoi,A. et al. (1987) Diisopropanolnitrosamine (DIPN) induced rat thyroid lesions. I. A histological classification. Acta. Pathol. Jpn., 37, 965-973.
18. Kawamori,T. et al. (1995) Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res., 55, 1277-1282.
19. Takahashi,M. et al. (2003) Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci., 95, 475-480.
20. Hundahl,S.A. et al. (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83, 2638-2648.
21. Ezaki,H. et al. (1992) Analysis of thyroid carcinoma based on material registered in Japan during 1977-1996 with special reference to predominance of papillary type. Cancer 70, 808-814.
22. Brennan,M.D. et al. (1991) Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin. Proc., 66, 105-111.
23. DeGroot,L.J. et al. (1990) Natural history, treatment, and course,of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 71, 414-424.
24. Lerch,H. et al. (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J. Clin. Oncol., 15, 2067-2075.
25. McConahey,W.M. et al. (1986) Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin. Proc., 61, 978-996.
26. Samaan,N.A. et al. (1992) The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients. J. Clin. Endocrinol. Metab., 75, 714-720.
27. Giuffirida,D. et al. (2000) Anaplastic thyroid carcinoma: Current diagnosis and treatment. Ann. Oncol., 11, 1083-1089.
28. Kitamura,Y. et al. (1999) Immmediate causes of death in thyroid carcinoma: Clinicopathological analysis of 161 fatal cases. J. Clin. Endocrinol. Metab., 84, 4043-4049.
29. Carcangiu,M.L. et al. (1985) Anaplastic thyroid carcinoma. A study of 70 cases. Am J. Clin. Pathol., 83, 135-158.
30. Nel,C.J. et al. (1985) Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases. Mayo Clin. Proc., 60, 51-58.
31. Patel,K.N. et al. (2006) Poorly differentiated and anaplastic thyroid cancer. Cancer Control, 13, 119-128.
32. Zheng,P. et al. (2006) Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol. Int., 56, 240-245.
33. Mitsumori,K. et al. (1995) Effect of thyroid stimulating hormone on the development and progression of rat thyroid follicular cell tumors. Cancer Lett., 92, 193-202.
34. Hasumura,M. et al. (2005) Promotion of thyroid carcinogenesis by paraaminobenzoic acid in rats initiated with N bis(2-hydroxypropyl)nitrosamine. Toxicol. Sci., 86, 61-67.
35. Son,H.Y. et al. (2003) Prolonged effects of beta-estradiol 3-benzoate on thyroid tumorigenesis in gonadectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine. Cancer Lett., 190 21-29.
36. Yasuhara,K. et al. (2001) Promoting effects of xylazine on development of thyroid tumors in rats initiated with N bis(2-hydroxypropyl)nitrosamine and the mechanism of action. Carcinogenesis, 22, 613-618.
37. Cipolla,C. et al. (2005) Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg., 71, 874-878.
38. Kung,A.W et al. (1995) Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin. Endocrinol., 43, 445-449.
39. Niho,N. et al. (2005) Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc. Natl Acad Sci. USA., 102, 2970-2974.
40. Niho,N. et al. (2003) Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res., 63, 6090-6095.
41. Terai,K. et al. (2006) Greater development of 1,2-dimethylhydrazine-induced colon cancer in a rat model of type 2 diabetes mellitus. J. Int. Med Res., 34, 385-389.